Definium Therapeutics (DFTX) Retained Earnings (2020 - 2026)
Definium Therapeutics (DFTX) reported Retained Earnings of $824000.0 for Q1 2026, up 100.2% year-over-year from $411598.3 in Q1 2025, and down 24.06% quarter-over-quarter from $1.1 million in Q4 2025.
Definium Therapeutics (DFTX) Retained Earnings (2020 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 7 years of Retained Earnings data on file, last reported at $824000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at $824000.0, up 100.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $824000.0 (up 100.2% YoY), and the FY2025 annual result was $1.1 million, up 100.27% from the prior year.
- Retained Earnings slipped to $824000.0 in Q1 2026 per DFTX's latest filing, from $1.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $1.1 million in Q4 2025 and troughed at -$532.2 million in Q3 2025.
- A 5-year average of -$142.6 million and a median of $627000.0 in 2022 frame the typical range for Retained Earnings.
- On a YoY basis, Retained Earnings climbed as much as 100.34% in 2024 and fell as far as 116391.25% in 2024.
- A 5-year view of Retained Earnings shows it stood at $627000.0 in 2022, then sank by 45.3% to $343000.0 in 2023, then tumbled by 116391.25% to -$398.9 million in 2024, then jumped by 100.27% to $1.1 million in 2025, then slipped by 24.06% to $824000.0 in 2026.
- Business Quant data shows DFTX's Retained Earnings at $824000.0 in Q1 2026, $1.1 million in Q4 2025, and -$532.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | 824,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 824,000.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | -532.20 Mn |
| Jun 30, 2025 | 807,000.00 |
| Mar 31, 2025 | -422.20 Mn |
| Dec 31, 2024 | -398.88 Mn |
| Sep 30, 2024 | 821,000.00 |
| Jun 30, 2024 | 833,000.00 |
| Mar 31, 2024 | -344.60 Mn |
| Dec 31, 2023 | 343,000.00 |
| Sep 30, 2023 | -266.30 Mn |
| Jun 30, 2023 | -248.41 Mn |
| Mar 31, 2023 | -219.30 Mn |
| Dec 31, 2022 | 627,000.00 |
| Sep 30, 2022 | 743,000.00 |
| Jun 30, 2022 | 850,000.00 |
| Mar 31, 2022 | 997,000.00 |
| Dec 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | -44.64 Mn |